Research advancements in palm oil nutrition

European Journal of Lipid Science and Technology

Volumn 116, Issue 10, 2014, Pages 1301-1315

  May, Choo Yuen ^a   Nesaretnam, Kalanithi ^a  

^a MALAYSIAN PALM OIL BOARD   (Malaysia)

Author keywords

Health; Lipid; Nutrition; Palm oil; Palm olein; Phytonutrient

Indexed keywords

EID: 84907948765     PISSN: 14387697     EISSN: 14389312     Source Type: Journal    
DOI: 10.1002/ejlt.201400076     Document Type: Article

References (126)

1. Honstra, G., in: Lands, W. E. M., (Ed.) Polyunsaturated Fatty Acids and Eicosanoids, Americal oil Chemists Society, Champaign, Illinois 1987, pp. 408-412.
2. Augustine Ong, S. H., Goh, S. H., Palm oil: A healthful and cost-effective dietary component. Food Nutr. Bull. 2002, 23, 11-22.
3. Interim Summary of Conclusions and Dietary Recommendations On Total Fat & Fatty Acids. Joint FAO/WHO Expert Consultation on Fats and Fatty Acids in Human Nutrition, November 10-14, 2008, WHO HQ, Geneva. http://www.fao.org/ag/agn/nutrition/docs/Fats%20and%20Fatty%20Acids%20Summary.pdf.
4. McMurray, J., Biomolecules: Lipids. Organic Chemistry, 5th Edn., Thomson Learning, 2000.
5. Goh, S. H., Oils and fats in nutrition and health: 2. Chemistry, digestion and metabolism. Malays. Oil Sci. Technol. 2006, 15, 43-63.
6. Straarup, E. M., Lauritzen, L., Faerk, J., Hoy, C. E., Michaelsen, K. F., The stereospecific triacylglycerol structures and fatty acid profiles of human milk and infant formulas. J Pediatr. Gastroenterol. Nutr. 2006, 42, 293-299.
7. Bottino, N. R., Vandenburg, G. A., Reiser, R., Resistance of certain long-chain polyunsaturated fatty acids of marine oils to pancreatic lipase hydrolysis. Lipids 1967, 2, 489-493.
8. Filer, L. J., Mattson, F., Fomon, S. J., Triglyceride configuration and fat absorption by the human infant. J. Nutr. 1969, 99, 293-298.
9. Bracco, U., Effect of triglyceride structure on fat absorption. Am. J. Clin. Nutr. 1994, 60 (suppl), 1002S-1009S.
10. Innis, S. M., Dyer, R., Lien, E. L., Formula containing randomized fats with palmitic acid (16:0) in the 2-position increases 16:0 in the 2-position of plasma and chylomycron tryacylglycerols in formula fed piglets to levels approaching those of piglets fed sow's milk. J. Nutr. 1997, 127, 1362-1370.
11. Ng, T. K. W., Hayes, K. C., De Witt, G. F., Jegathesan, M., et al., Plamitic and oleic acids exert similar effects on lipid profiles in normocholesterolemic humans. J. Am. Coll. Nutr. 1992, 11, 383-390.
12. Choudhury, N., Tan, L., Truswell, A. S., Comparison of POo and olive oil: Effects on plasma lipids and vitamin E in young adults. Am. J. Clin. Nutr. 1995, 61, 1043-1051.
13. Voon, P. T., Ng, T. K. W., Lee, V. K. M., Nesaretnam, K., Diets high in palmitic acid (16: 0), lauric and myristic acids (12: 0+ 14: 0), or oleic acid (18: 1) do not alter postprandial or fasting plasma homocysteine and inflammatory markers in healthy Malaysian adults. Am. J. Clin. Nutr. 2011, 94, 1451-1457.
14. Rand, M. L., Hennissen, A. A., Hornstra, G., Effects of dietary palm oil on arterial thrombosis, platelet responses and platelet membrane fluidity in rats. Lipids 1988, 23, 1019-1023.
15. Oluba, O. M., Adeyemi, O., Ojieh, G. C., Aboluwoye, C. O., Eidangbe, G. O., Comparative effect of soybean oil and palm oil on serum lipids and some serum enzymes in cholesterol-fed rats. Eur. J. Sci. Res. 2008, 23, 559-566.
16. Gouk, S. W., Cheng, S. F., Mok, J. S. L., Ong, A. S. H., Chuah, C. H., Long-chain SFA at the sn-1, 3 positions of TAG reduce body fat deposition in C57BL/6 mice. Br J Nutr. 2013, 110, 1987-1995.
17. Gouk, S. W., Cheng, S. F., Ong, A. S. H., Chuah, C. H., Stearic acids at sn-1, 3 positions of TAG are more efficient at limiting fat deposition than palmitic and oleic acids in C57BL/6 mice. Br J Nutr. 2014, 111, 1174-1180.
18. Khosla, P., Pronzuk, A., Hajri, T., Hayes, K. C., Dietary oleic and palmitic acid exert similar effects on plasma lipids and lipoprotein metabolism in hamster fed purified diets with low cholesterol but different quantities of fat. Asia Pac. J. Clin. Nutr. 1997, 6, 26-30.
19. Wilson, T. A., Nicolosi, R. J., Kotyla, T., Sundram, K., Kritchevsky, D., Different palm oil preparations reduce plasma cholesterol concentrations and aortic cholesterol accumulation compared to coconut oil in hypercholesterolemic hamsters. J. Nutr. Biochem. 2005, 16, 633-640.
20. Van Jaarsveld, P. J., Benade, A. J., Effects of POo oil in a moderate-fat diet on low-density lipoprotein composition in non-human primates. Asia Pac. J. Clin. Nutr. 2002, 11, S416-423.
21. Kritchevsky, D., Tepper, S. A., Kuksis, A., Wright, S., Czarnecki, S. K., Cholesterol vehicle in experimental atherosclerosis. 22. Refined, bleached, deodorized (RBD) palm oil, randomized palm oil and red palm oil. Nutr. Res. 2000a, 20, 887-892.
22. Kritchevsky, D., Tepper, S. A., Chen, S. C., Meijer, G. W., Krauss, R. M., Cholesterol vehicle in experimental atherosclerosis. 23. Effects of specific synthetic triglycerides. Lipids 2000b, 35, 621-625.
23. Ng, T. K. W., Hassan, K., Lim, J. B., Lye, M. S., Ishak, R., Non hypercholesterolemic effects of a palm-oil diet in Malaysian volunteers. Am. J. Clin. Nutr. 1991, 53, 1015S-1020S.
24. Zock, P. L., De Vries, J. H., Katan, M. B., Impact of myristic acid versus palmitic acid on serum lipid and lipoprotein levels in healthy women and men. Arterioscler. Thromb. 1994, 14, 567-575.
25. Sundram, K., Hayes, K. C., Siru, O. H., Dietary palmitic acid results in lower serum cholesterol than does a lauric-myristic acid combination in normolipemic humans. Am. J. Clin. Nutr. 1994, 59, 841-846.
26. Nestel, P. J., Pomeroy, S., Kay, S., Sasahara, T., Yamashita, T., Effect of a stearic acid-rich, structured triacylglycerol on plasma lipid concentrations. Am. J. Clin. Nutr. 1998, 68, 1196-1201.
27. Kelly, F. D., Sinclair, A. J., Mann, N. F., Turner, A. H., et al., Short-term diets enriched in stearic or palmitic acids do not alter plasma lipids, platelet aggregation or platelet activation status. Eur. J. Clin. Nutr. 2002, 56, 490-499.
28. Truswell, A. S., Choudhury, N., Roberts, D. C., Double blind comparison of plasma lipids in healthy subjects eating potato crisps fried in palm olein or canola oil. Nutr. Res. 1992, 12, S43-S52.
29. Voon, P. T., Ng, T. K. W., Kar, M. L., Nesaretnam, K., Diets high in palmitic acid (16:0), lauric and myristic acids (12:0 + 14:0), or oleic acid (18:1) do not alter postprantidal or fasting plasma homocysteine and inflammatory markers in healthy Malaysian adults. Am. J. Clin. Nutr. 2011, 94, 1451-1457.
30. Sundram, K., Hayes, K. C., Siru, O. H., Both dietary 18:2 and 16:0 may be required to improve the serum LDL/HDL cholesterol ratio in normocholesterolemic men. J. Nutr. Biochem. 1995, 4, 179-187.
31. Scholtz, S. C., Pieters, M., Oosthuizen, W., Jerling, J. C., et al., The effect of red palm olein and refined palm olein on lipids and haemostatic factors in hyperfibrinogenaemic subjects. Thromb. Res. 2004, 113, 13-25.
32. Zhang, J., Wang, C., Dai, J., Chen, X., Ge, K., Palm oil may benefit midly hypercholesterolemic Chinese adults. Asia Pac. J. Clin. Nutr. 1997, 6, 22-25.
33. Ghafoorunissa, Reddy, V., Sesikaran, B., Palm olein and groundnut oil have comparable effects on blood lipids and platelet aggregation in healthy Indian subjects. Lipids 1995, 30, 1163-1169.
34. Marzuki, A., Arshad, F., Razak, T. A., Jaarin, K., Influence of dietary fat on plasma lipid profiles of Malaysian adolescents. Am. J. Clin. Nutr. 1991, 53, 1010S-1014S.
35. Hayes, K. C., Khosla, P., Dietary fatty acid thresholds and cholesterolemia. FASEB J. 1992, 6, 2600-2607.
36. Clandinin, M. T., Cook, S. L., Konrad, S. D., Goh, Y. K., French, M. A., The effect of palmitic acid on lipoprotein cholesterol levels and endogenous cholesterol synthesis in hyperlipidemic subjects. Lipids 1999, 34, S121-124.
37. Clandinin, M. T., Cook, S. L., Konrad, S. D., French, M. A., The effect of palmitic acid on lipoprotein cholesterol levels. Int. J. Sci. Nutr. 2000, 51 (suppl), S61-71.
38. Mukherjee, S., Mitra, A., Health effects of palm oil. J. Hum. Ecol. 2009, 26, 197-203.
39. Mozaffarian, D., Katan, M. B., Ascherio, A., Stampfer, M., Willett, W., Trans fatty acids and cardiovascular disease. N. Engl. J. Med. 2006, 354, 1601-1613.
40. Mozaffarian, D, Abdollahi, M, Campos, H, Houshiarrad, A, Willett, W C, Consumption of trans fats and estimated effects on coronary heart disease in Iran. Eur. J. Clin. Nutr. 2007, 61, 1004-1010.
41. Mozaffarian, D., Clarke, R., Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils. Eur. J. Clin. Nutr. 2009, 63 (Suppl 2), S22-33.
42. Ascherio, A., Rimm, E. B., Giovannucci, E. L., Spiegelman, D., et al., Dietary fat and risk of coronary heart disease in men: Cohort follow-up study in the United States. BMJ 1996, 313, 84-90.
43. Hu, F. B., Stampfer, M. J., Manson, J. E., Rimm, E., et al., Dietary fat intake and the risk of coronary heart disease in women. N. Engl. J. Med. 1997, 337, 1491-1499.
44. Pietinen, P., Ascherio, A., Korhonen, P., Hartman, A. M., et al., Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men. The alpha-tocopherol, beta-carotene cancer prevention study. Am. J. Epidemiol. 1997, 145, 876-887.
45. Oomen, C. M., Ocke, M. C., Feskens, E. J., Van Erp-Baart, M. A., et al., Association between trans fatty acid intake and 10-year risk of coronary heart disease in the Zutphen Elderly Study: A prospective population-based study. Lancet 2001, 357, 746-751.
46. Oh, K., Hu, F. B., Manson, J. E., Stampfer, M. J., Willett, W. C., Dietary fat intake and risk of coronary heart disease in women: 20 years of follow-up of the Nurse's Health Study. Am. J. Epidemiol. 2005, 161, 672-679.
47. Mensink, R. P., Zock, P. L., Kester, A. D., Katan, M. B., Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: A meta-analysis of 60 controlled trials. Am. J. Clin. Nutr. 2003, 77, 1146-1155.
48. Sundram, K., Ismail, A., Hayes, K. C., Jeyamalar, R., Pathmanathan, R., Trans (elaidic) fatty acids adversely affect the lipoprotein profile relative to specific saturated fatty acids in humans. J. Nutr. 1997, 127, 514S-520S.
49. Nestel, P., Noakes, M., Belling, B., Mcarthur, R., et al., Plasma lipoprotein lipid and Lp (a) changes with substitution of elaidic acid for oleic acid in the diet. J. Lipid Res. 1992, 33, 1029-1036.
50. Pedersen, J. I., Muller, H., Seljeflot, I., Kirkhus, B., Palm oil versus hydrogenated soybean oil: Effects on serum lipids and plasma haemostatic variables. Asia Pac. J. Clin. Nutr. 2005, 14, 348-357.
51. Teng, K.-T., Voon, P.-T., Cheng, H.-M., Nesaretnam, K., Effects of partially hydrogenated, semi-saturated, and high oleate vegetable oils on inflammatory markers and lipids. Lipids 2010, 45, 385-392.
52. Goh, S. H., Choo, Y. M., Ong, S. H., Minor constituents of palm oil. J. Am. Oil Chem. Soc. 1985, 62, 237-240.
53. Choo, Y. M., Lau, H. L., Puah, C. W., Bong, S. C., et al., Production of phytonutrients (carotenes, vitamin e, sterols, squalene, coenzyme Q and phospholipids) from palm methyl esters. MPOB Information Series.MPOB TT No. 348. 2002.
54. Nesaretnam, K., Guthrie, N., Chambers, A. F., Carroll, K. K., Effect of tocotrienols on the growth of a human breast cancer cell line in culture. Lipids 1995, 30, 1139-1142.
55. Ng, M. H., May, C. Y., Chromatographic analyses of tocopherols and tocotrienols in palm oil. J. Chromatogr. Sci. 2012, 50, 283-286.
56. Das, S., Lekli, I., Das, M., Szabo, G., Cardioprotection with palm oil tocotrienols: Comparison of different isomers. Am. J. Physiol. Heart. Clin. Physiol. 2008, 294, 70-78.
57. Qureshi, A. A., Qureshi, N., Wright, J. J. K., Shen, Z., et al., Lowering of serum cholesterol in hypercholesterolemic humans by tocotrienols (palmvitee). Am. J. Clin. Nutr. 1991, 53, 1021S-1026S.
58. Parker, R. A., Pearce, B. C., Clark, R. W., Gordon, D. A., Tocotrienols regulate cholesterol production in mammalian cells by post transcriptional suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase. J. Biol. Chem. 1993, 268, 11230-11238.
59. Song, B. L., Boyd, R. A. D., Insign-dependent ubiquination and degradation of 3-hydroxy-3-methylglutaryl coenzyme A reductase stimulated by δ- and γ tocotrienols. J. Biol. Chem. 2006, 281, 25054-25061.
60. Tomeo, A. C., Geller, M., Watkins, T. R., Gapor, A., Bierenbaum, M. L., Antioxidant effects of tocotrienols in patients with hyperlipidemia and carotid stenosis. Lipids 1995, 30, 1179-1183.
61. Qureshi, A. A., Sami, S. A., Salser, W. A., Khan, F. A., Dose-dependent suppression of serum cholesterol by tocotrienol-rich fraction (TRF25) of rice bran and in hypercholesterolemic humans. Atherosclerosis 2002, 161, 199-207.
62. Rasool, A. H., Rahman, A. R., Yuen, K. H., Wong, A. R., Arterial compliance and vitamin E blood levels with a self-emulsifying preparation of tocotrienol rich vitamin E. Arch. Pharm. Res. 2008, 31, 1212-1217.
63. Miyazawa, T., Shibata, A., Nakagawa, K., Tsuzuki, T., Anti-angiogenic function of tocotrienol. Asia Pac. J. Clin. Nutr. 2008, 7, 253-256.
64. Shibata, A., Nakagawa, K., Sookwong, P., Tsuzuki, T., et al., Tumor anti-angiogenic effect and mechanism of action of δ tocotrienol. Biochem. Pharmacol. 2008, 76, 330-339.
65. Wong, W. Y., Selvaduray, K. R., Ming, C. H., Nesaretnam, K., Suppression of tumor growth by palm tocotrienols via the attenuation of angiogenesis. Nutr. Cancer 2009, 61, 367-373.
66. Selvaduray, K. R., Radhakrishnan, A. K., Kutty, M. K., Nesaretman, K., Palm tocotrienols decrease levels of pro-angiogenic markers in human umbilical vein endothelial cells (HUVEC) and murine mammary cancer cells. Genes Nutr. 2012, 7, 53-61.
67. Suarna, C., Hood, R. L., Dean, R. T., Stocker, R., Comparative antioxidant activity of tocotrienols and other natural lipid-soluble antioxidants in a homogeneous system, and in rat and human lipoproteins. Biochim. Biophys. Acta. 1993, 1166, 163-170.
68. Azlina, M. F. N., Nafeera, M. I., Khalid, B. A. K., Effect of tocotrienol on lipid peroxidation in experimental gastritis induced by restraint stress. Pak. J. Nutr. 2005, 4, 69-72.
69. Suzana, M., Suhana, M., Zalinah, A., Gapor, M. T., Wan Ngah, W. Z., Comparative effects of alpha-tocopherol and gamma-tocotrienol on lipid peroxidation status in Hep G2 cell line transfected with CYP2E1 gene. Eur. J. Sci. Res. 2005, 7, 41-56.
70. Nesaretnam, K., Stephen, R., Dils, R., Darbre, P., Tocotrienols inhibits the growth of human breast cancer cells irrespective of estrogen receptor status. Lipids 1998, 33, 461-469.
71. Nesaretnam, K., Ambra, R., Selvaduray, K. R., Radhakrishnan, A., et al., Tocotrienol-rich fraction from palm oil affects gene expression in tumors resulting from MCF-7 cell inoculation in athymic mice. Lipids 2004, 39, 459-467.
72. Nesaretnam, K., Koon, T. H., Selvaduray, K. R., Bruno, R. S., Ho, E., Modulation of cell growth and apoptosis response in human prostate cancer cells supplemented with tocotrienols. Eur. J. Lipid Sci. Technol. 2008, 110, 23-31.
73. Yu, F. L., Gapor, A., Bender, W., Evidence for the preventive effect of the polyunsaturated phytol side chain in tocotrienols on 17β-estradiol epoxidation. Cancer Detect. Prev. 2005, 29, 383-388.
74. Srivastava, J. K., Gupta, S., Tocotrienol-rich fraction of palm oil induces cell cycle arrest and apoptosis selectively in human prostate cancer cells. Biochem. Biophys. Res. Commun. 2006, 346, 447-453.
75. Selvaduray, K. R., Radhakrishnan, A. K., Kutty, M. K., Nesaretnam, K., Palm tocotrienols inhibit proliferation of murine mammary cancer cells and induce expression of interleukin-24 mRNA. J. Interferon. Cytokine. Res. 2010, 30, 909-916.
76. Hafid, S. R. A., Radhakrishnan, A. K., Nesaretnam, K., Tocotrienols are good adjuvants for developing cancer vaccines. BMC Cancer 2010, 10, 5.
77. Hafid, S. R. A., Chakravarthi, S., Nesaretnam, K., Radhakrishnan, A. K., Tocotrienol-adjuvanted dendritic cells inhibit tumor growth and metastasis: A murine model of breast cancer. PloS One 2013, 8, e74753.
78. Yam, M. L., Abdul Hafid, S. R., Cheng, H. M., Nesaretnam, K., Tocotrienols suppress proinflammatory markers and cyclooxygenase-2 expression in RAW264.7 macrophages. Lipids 2009, 44, 787-797.
79. Zainal, Z., Shahrim, Z., Gamma-tocotrienol from Palm Oil for Athritis (12MY39) MALAYSIAN Patent Application No. PI 2011005682.
80. Hermizi, H., Faizah, O., Ima-Nirwana, S., Beneficial effects of tocotrienol and tocopherol on bone histomorphometric parameters in Sprague-Dawley male rats after nicotine cessation. Calcif. Tissue Int. 2009, 84, 65-74.
81. Ima Nirwana, S., Wang, M., Roshayati, A. B., Nursyahrina, A. H., et al., Palm tocotrienol supplementation enhanced bone formation in oestrogen-deficient rats. Int. J. Endocrinol. 2012, 2012, Article ID 532862.
82. Yamada, Y., Obayashi, M., Ishikawa, T., Kiso, Y., et al., Dietry tocotrienl reduces UVB-induced skin damage and sesamin enhances tocotrienol effects in hairless mice. J. Nutr. Sci. Vitaminol 2008, 54, 117-123.
83. Shibata, A., Nakagawa, K., Kawakami, Y., Tsuzuki, T., Miyazawa, T., Suppression of gamma-tocotrienol on UVB induced inflammation in HaCaT keratinocytes and HR-1 hairless mice via inflammatory mediators multiple signaling. J. Agric. Food Chem. 2010, 58, 7013-7020.
84. Pedrelli, V. F., Lauriola, M. N., Pigatto, P. D., Clinical evaluation of photoprotective effect by a topical antioxidants combination (tocopherols and tocotrienols). JEADV 2011, 26, 1449-1453.
85. Budin, S. B., Othman, F., Louis, S. R., Bakar, M. A., et al., The effects of palm oil tocotrienol-rich fraction supplementation on biochemical parameters, oxidative stress and the vascular wall of streptozotocin-induced diabetic rats. Clinics 2009, 64, 235-244. doi: 10.1590/S1807-59322009000300015.PMC2666447. PMID 19330251.
86. Muharis, S. P., Md Top, A. G., Murugan, D., Mustafa, M. R., Palm oil tocotrienol fractions restore endothelium dependent relaxation in aortic rings of streptozotocin-induced diabetic and spontaneously hypertensive rats. Nutr. Res. 2010, 30, 209-216.
87. c-Src kinase activation and death of HT4 neuronal cells. J. Biol. Chem. 2000, 275, 13049-13055.
88. Sen, C. K., Rink, C., Khanna, S., Palm oil-derived natural vitamin E alpha-tocotrienol in brain health and diseases. J. Am. Coll. Nutr. 2010, 29, 314S-323S.
89. Khanna, S., Roy, S., Slivka, A., Craft, T. K., et al., Neuroprotective properties of the natural vitamin E alpha-tocotrienol. Stroke 2005, 36, 2258-2264.
90. Choo, Y. M., Palm oil carotenoids. Food Nutr. Bull. 1994, 15
91. Wattanapenpaiboon, N., Wahlqvist, M. L., Phytonutrient deficiency: The place of palm fruit. Asia Pac. J. Clin. Nutr. 2003, 12, 363-368.
92. Canfield, L. M., Kaminsky, R. G., Red palm oil in the maternal diet improves the vitamin status of lactating mothers and their infants. Food Nutr. Bull. 2000, 21, 144-148.
93. Lietz, G., Henry, C. J. K., Mulokozi, G., Mugyabuso, J., et al., Use of red palm oil for the promotion of maternal vitamin A status. Food Nutr. Bull. 2000, 21, 215-218.
94. Stuijvenberg, M. E. V., Benade, A. J. S., South Africa experience with the use of red palm oil to improve the vitamin A status of primary schoolchildren. Food Nutr. Bull. 2000, 21, 212-214.
95. Rao, N. B. S., Potential use of red palm oil in combating vitamin deficiency in India. Food Nutr. Bull. 2000, 21, 202-211.
96. Scrimshaw, N. S., Nutritional potential of red palm oil for combating vitamin A deficiency. Food Nutr. Bull. 2000, 21, 195-201.
97. Rooyen, J. V., Esterhuyse, A. J., Engelbrecht, A. M., Toit, E. F., Health benefits of a natural carotenoid rich oil: A proposed mechanism of protection against ischemia/reperfusion injury. Asia Pac. J. Clin. Nutr. 2008, 17, 316-319.
98. Nesaretnam, K., Radhakrishnan, A., Selvaduray, K. R., Reimann, K., et al., Effect of palm oil carotene on breast cancer tumorigenicity in nude mice. Lipids 2002, 37, 557-560.
99. Toniola, P., Kappel, A. L. V., Akhmedkhanov, A., Ferrari, P., et al., Serum carotenoids and breast cancer. Am. J. Epidemiol. 2001, 153, 1142-1147.
100. Zhang, S., Hunter, D. J., Forman, M. R., Rosner, B. A., et al., Dietarycarotenoids and vitamins A, C, and E and risk of breast cancer. J. Natl. Cancer Inst. 1999, 91, 547-556.
101. Tamimi, R. M., Hankinson, S. E., Campos, H., Spiegelman, D., et al., Plasma carotenoids, retinol, and tocopherols and risk of breast cancer. Am. J. Epidemiol. 2005, 161, 153-160.
102. 10 in palm oil by supercritical fluid chromatography. Am. J. Appl. Sci. 2006, 3, 1929-1932.
103. Niklowitz, P., Sonnenschein, A., Janetzky, B., Andler, W., Menke, T., Enrichment of coenzyme Q10 in plasma and blood cells: Defense against oxidative damage. Int. J. Biol. Sci. 2007, 3, 257-262.
104. Verma, D. D., Hartner, W. C., Thakkar, V., Levchenko, T. S., Torchilin, V. P., Protective effect of coenzyme Q10-loaded liposomes on the myocardium in rabbits with an acute experimental myocardial infarction. Pharm. Res. 2007, 24, 2131-2137.
105. Burke, B., Neuenschwander, E., Olson, R. R. D., Randomized, double-blind, placebo-controlled trial of coenzyme q10 in isolated systolic hypertension. South. Med. J. 1994, 94, 1112-1117.
106. Portakal, O., Ozkaya, O., Inai, M. E., Bozan, B., et al., Coenzyme Q10 concentrations and antioxidant status in tissues of breast cancer patients. Clin. Biochem. 2000, 33, 279-284.
107. Smith, T. J., Yang, G. Y., Seril, D N; Liao, J., Kim, S., Inhibition of 4 (methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis by dietary olive oil and squalene. Carcinogenesis 1998, 19, 703-706.
108. Rao, C. V., Newmark, H. L., Reddy, B. S., Chemopreventive effect of squalene on colon cancer. Carcinogenesis 1998, 19, 287-290.
109. Murakoshi, M., Nishino, H., Satomi, Y., Takayasu, J., et al., Potent preventive action of α-carotene against carcinogenesis: Spontaneous liver carcinogenesis and promoting stage of lung and skin carcinogenesis in mice are suppressed more effectively by α-carotene than by β-carotene. Cancer Res 1992, 52, 6583-6587.
110. Miettinen, T. A., Vuoristo, M., Nissinen, M., Järvinen, H. J., Gylling, H., Serum, biliary, and fecal cholesterol and plant sterols in colectomized patients before and during consumption of stanol ester margarine 1-3. Am. J. Clin. Nutr. 2000, 71, 1095-1102.
111. Jones, P. J. H., Raeini-Sarjaz, M., St-Onge, M., Phytosterols in low- and non-fat beverages as part of a controlled diet fail to lower plasma lipid levels. J. Lipid Res. 2003, 44, 1713-1719.
112. Zadak, Z., Hyspler, R., Ticha, A., Solichova, D., et al., Poly-unsaturated fatty acids, phytosterols and cholesterol metabolism in the Mediterranean diet. Acta. Medica. 2006, 49, 23-26.
113. Awad, A., Fink, B. C. S., Phytosterol as anticancer dietary components: Evidence and mechanism of action. Am. Soc. Nutr. Sci., 2000, 130, 2127-2130.
114. Bouic, P. J. D., Etsebeth, S., Liebenberg, R. W., Albrecht, C. F., Pegel, K., Beta-sitosterol and Beta-sitosterol glucoside stimulate human peripheral blood lymphocyte proliferation: Implications for their use as an immunomodulatory vitamin combination. Int. J. Immunopharmacol. 1996, 18, 693-700.
115. Tan, Y. A., Sambanthamurthi, R., Sundram, K., Wahid, M. B., Valorisation of palm byproducts as functional components. Eur. J. Lipid Sci. Technol. 2007, 109, 380-393.
116. Sambanthanurthi, R., Tan, Y. A., Sundram, K., Treatment of vegetation liquors derived from oil-bearing fruits. United States patent 7387802. (2011).
117. Ebrahimzadeh, M. A., Pourmorad, F., Bekhradnia, A. R., Iron chelating activity, phenol and flavonoid content of some medicinal plants from Iran. Afr. J. Biotechnol. 2008, 7, 3188-3192.
118. Sambanthamurthi, R., Tan, Y. A., Sundram, K., Treatment of vegetation liquors derived from oil-bearing fruit. Malaysian Palm Oil Board: United States Patent US 7387802, B2. (2008).
119. Fink, B. N., Steck, S. E., Wolff, M. S., Britton, J. A., et al., Dietary flavonoid intake and breast cancer risk among women on Long Island. Am. J. Epidemiol. 2007, 165, 514-523.
120. Nair, H. K., Rao, K. V. K., Aalinkeel, R. M., Supriya, M., et al., Inhibition of prostate cancer cell colony formation by the flavonoid quercetin correlates with modulation of specific regulatory genes. Clin. Diag. Lab. Immunol. 2004, 11, 63-69.
121. Guthrie, N., Gapor, A., Chambers, A. F., Carroll, K. K., Palm oil tocotrienols and plant flavonoids act synergistically with each other and with Tamoxifen in inhibiting proliferation and growth of estrogen receptor-negative MDA-MB-435 and -positive MCF-7 human breast cancer cells in culture. Asia Pac. J. Clin. Nutr. 1997, 6, 41-45.
122. Aviram, M., Fuhrman, B., Polyphenolic flavonoids inhibit macrophage- mediated oxidation of LDL and attenuate atherogenesis. Atherosclerosis 1998, 137, S45-S50.
123. Jager, R., Purpura, M., Kingsley, M., Phospholipids and sports performance. J. Int. Soc. Sports Nutr. 2007, 4, 1-8.
124. Suzuki, S., Yamatoya, H., Sakai, M., Kataoka, A., et al., Oral administration of soybean lecithin transphosphatidylated phosphatidylserine improves memory impairment in aged rats. J. Nutr. 2001, 131, 2951-2956.
125. Starks, M. A., Starks, S. L., Kingsley, M., Purpura, M., Jager, R., The effects of phosphatidylserine on endocrine response to moderate intensity exercise. J. Int. Soc. Sports Nutr. 2008, 5, 1-6.
126. Lochmann, R., Brown, R., Soybean-lecithin supplementation of practical diets for juvenile goldfish (Carassius auratus). J. Am. Oil Chem. Soc. 1997, 74, 149-152.